Using a combination of methylated ALX4, SEPT9, and TMEFF2 as biomarkers, the sensitivity for detecting CRC in primary tissue and peripheral blood samples was 84% and 81%, with 87% and 90% specificities, respectively [11]. Here, SEPTIN9 is linked to colorectal carcinoma.